[미국특허]
Drug delivery systems for photodynamic therapy
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-031/00
A61K-009/14
출원번호
US-0851641
(2001-05-08)
발명자
/ 주소
Chowdhary, Rubinah K.
Dolphin, David
출원인 / 주소
The University of British Columbia (UBC)
대리인 / 주소
Morrison & Foerster, LLP
인용정보
피인용 횟수 :
13인용 특허 :
13
초록▼
The invention is generally related to the field of photodynamic therapy by use of photosensitizers and stabilized formulations of the photosensitizers. These formulations may be used to deliver a photosensitizer as a pharmaceutical, agricultural, or industrial agent. The photosensitizer containing f
The invention is generally related to the field of photodynamic therapy by use of photosensitizers and stabilized formulations of the photosensitizers. These formulations may be used to deliver a photosensitizer as a pharmaceutical, agricultural, or industrial agent. The photosensitizer containing formulations and compositions of the invention comprise one or more block copolymers. Furthermore, the invention relates to processes for the production of, and application of, said formulations and compositions as photosensitizer drug delivery systems.
대표청구항▼
1. A method for formulating a photosensitizer carrier composition comprising combining one or more photosensitizer and one or more block copolymer in solution and drying said photosensitizer and copolymer combination, wherein said copolymer is i) not an amphiphilic polymer of polystyrene sodium
1. A method for formulating a photosensitizer carrier composition comprising combining one or more photosensitizer and one or more block copolymer in solution and drying said photosensitizer and copolymer combination, wherein said copolymer is i) not an amphiphilic polymer of polystyrene sodium sulphonate and vinyl naphthalene, and ii) not poloxamer 188. 2. The method of claim 1 further comprising a step of hydrating said photosensitizer and copolymer combination to form a complex. 3. The method of claim 1, wherein said block copolymer comprises polyoxyethylene and polyoxypropylene; polytetrahydrofuran; or polyaspartic acid. 4. The method of claim 3, wherein said polyoxyethylene-polyoxypropylene block copolymer is selected from the group consisting of poloxamer 403 (P123), poloxamer 407 (F127), poloxamer 402 (L122), poloxamer 181 (L61), poloxamer 401 (L121), poloxamer 185 (P65), and poloxamer 338 (F108). 5. The method of claim 1, wherein said photosensitizer is selected from the group consisting of porphyrins, pyrroles, tetrapyrrolic compounds, expanded pyrrolic macrocycles and their derivatives. 6. The method of claim 5, wherein said derivative of porphyrin is selected from the group consisting of green porphyrins, tetrahydrochlorins, pyrophenophorphides, purpurins, texaphyrins, phenothiaziniums, phthalocyanines, napthalocyanines, porphycenes and pheophorbides. 7. The method of claim 6, wherein said tetrahydrochlorins are selected from the group consisting of chlorins, hydroxychlorins, bacteriochlorins, and isobacteriochlorins. 8. The method of claim 7, wherein said green porphyrin is a benzoporphyrin derivative (BPD). 9. The method of claim 8, wherein said BPD is selected from the group consisting of benzoporphyrin derivative monoacid ring A (BPD-MA), benzoporphyrin derivative monoacid ring B (BPD-MB), A-EA6, B-EA6, A-B3 and B-B3. 10. The method of claim 2, wherein said step of combining one or more photosensitizer and one or more block copolymer in solution further comprises a hydratable solid support on which said photosensitizer and block copolymer combination may deposit. 11. The method of claim 10, wherein said solid support is not capable of dissolving in said copolymer in solution. 12. The method of claim 10, wherein said solid support is capable of dissolving in said optional hydrating step. 13. A method for conducting photodynamic therapy comprising: (a) administering a photosensitizer and copolymer complex produced by the method of claim 2 to a subject in need of photodynamic therapy; and (b) irradiating said subject to activate said photosensitizer.
Sternberg Ethan D.,CAX ; Dolphin David,CAX ; Tovey Andrew,CAX ; Richter Anna M.,CAX ; Levy Julia G.,CAX, Class of benzoporphyrin derivative photoactive compounds.
Sternberg Ethan,CAX ; Dolphin David,CAX ; Levy Julia G.,CAX ; Richter Anna M.,CAX ; Hunt David W. C.,CAX ; Jain Ashok,CAX, Ethylene glycol esters as photoactive agents.
Boyle Ross W. (Vancouver CAX) Dolphin David (Vancouver CAX) Johnson Claire K. (Vancouver CAX), Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same.
Bruckner Christian,CAX ; Boyle Ross W.,GBX ; Dolphin David,CAX, Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same.
Levy Julia G. (Vancouver CAX) Dolphin David (Vancouver CAX) Chow Jack J. (Vancouver CAX) Sternberg Ethan (Vancouver CAX), Wavelength-specific cytotoxic agents.
Tang Hang (Montreal CAX) Xie Lily (Vancouver PA CAX) Wijesekera Tilak (Glen Mills PA) Dolphin David (Vancouver CAX), Wavelength-specific photosensitive compounds and expanded porphyrin-like compounds and methods of use.
Cantrell, Gary L.; Rajagopalan, Raghavan; Berberich, David W.; Karwa, Amolkumar; Dorshow, Richard B., Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers.
Cantrell, Gary L.; Rajagopalan, Raghavan; Karwa, Amolkumar; Dorshow, Richard B., Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers.
Cantrell, Gary L.; Rajagopalan, Raghavan; Karwa, Amolkumar; Dorshow, Richard B., Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers.
Haffner, David S.; Burns, Thomas W.; Heitzmann, Harold A.; Curry, Kenneth M., Implants with controlled drug delivery features and methods of using same.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.